183 related articles for article (PubMed ID: 23416466)
1. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.
Zeng L; Ehrenreiter K; Menon J; Menard R; Kern F; Nakazawa Y; Bevilacqua E; Imamoto A; Baccarini M; Rosner MR
Cell Signal; 2013 May; 25(5):1156-65. PubMed ID: 23416466
[TBL] [Abstract][Full Text] [Related]
2. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.
Trakul N; Menard RE; Schade GR; Qian Z; Rosner MR
J Biol Chem; 2005 Jul; 280(26):24931-40. PubMed ID: 15886202
[TBL] [Abstract][Full Text] [Related]
3. Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension.
Morecroft I; Doyle B; Nilsen M; Kolch W; Mair K; Maclean MR
Br J Pharmacol; 2011 Jul; 163(5):948-63. PubMed ID: 21385176
[TBL] [Abstract][Full Text] [Related]
4. The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK.
Rath O; Park S; Tang HH; Banfield MJ; Brady RL; Lee YC; Dignam JD; Sedivy JM; Kolch W; Yeung KC
Cell Signal; 2008 May; 20(5):935-41. PubMed ID: 18294816
[TBL] [Abstract][Full Text] [Related]
5. Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration.
Shemon AN; Eves EM; Clark MC; Heil G; Granovsky A; Zeng L; Imamoto A; Koide S; Rosner MR
PLoS One; 2009 Jun; 4(6):e6028. PubMed ID: 19551145
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.
Yeung K; Seitz T; Li S; Janosch P; McFerran B; Kaiser C; Fee F; Katsanakis KD; Rose DW; Mischak H; Sedivy JM; Kolch W
Nature; 1999 Sep; 401(6749):173-7. PubMed ID: 10490027
[TBL] [Abstract][Full Text] [Related]
8. Regulation of RKIP binding to the N-region of the Raf-1 kinase.
Park S; Rath O; Beach S; Xiang X; Kelly SM; Luo Z; Kolch W; Yeung KC
FEBS Lett; 2006 Nov; 580(27):6405-12. PubMed ID: 17097642
[TBL] [Abstract][Full Text] [Related]
9. Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush.
Wei J; Jiang H; Gao H; Wang G
J Mol Neurosci; 2015 Oct; 57(2):243-8. PubMed ID: 26160696
[TBL] [Abstract][Full Text] [Related]
10. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.
Yeung KC; Rose DW; Dhillon AS; Yaros D; Gustafsson M; Chatterjee D; McFerran B; Wyche J; Kolch W; Sedivy JM
Mol Cell Biol; 2001 Nov; 21(21):7207-17. PubMed ID: 11585904
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.
Ye CY; Zheng CP; Ying WW; Weng SS
Cell Cycle; 2018; 17(24):2666-2683. PubMed ID: 30382763
[TBL] [Abstract][Full Text] [Related]
12. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S; Garcia R; Dhillon A; Kolch W
Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
[TBL] [Abstract][Full Text] [Related]
13. A proteomic approach in investigating the hepatoprotective mechanism of Schisandrin B: role of raf kinase inhibitor protein.
Chen Y; Ip SP; Ko KM; Poon TC; Ng EW; Lai PB; Mao QQ; Xian YF; Che CT
J Proteome Res; 2011 Jan; 10(1):299-304. PubMed ID: 21155602
[TBL] [Abstract][Full Text] [Related]
14. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein.
Corbit KC; Trakul N; Eves EM; Diaz B; Marshall M; Rosner MR
J Biol Chem; 2003 Apr; 278(15):13061-8. PubMed ID: 12551925
[TBL] [Abstract][Full Text] [Related]
15. NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP.
Wen Y; Fan L; Pang L; Zhao T; Li R; Zhang Y; Zhang L; Yang W
Gynecol Endocrinol; 2022 Dec; 38(12):1136-1146. PubMed ID: 36592742
[TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
[TBL] [Abstract][Full Text] [Related]
17. Dioscorea nipponica Makino Relieves Ovalbumin-Induced Asthma in Mice through Regulating RKIP-Mediated Raf-1/MEK/MAPK/ERK Signaling Pathway.
Wang W; Xu L; Zhou L; Wan S; Jiang L
Biomed Res Int; 2022; 2022():8077058. PubMed ID: 35757465
[TBL] [Abstract][Full Text] [Related]
18. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
19. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
Karreth FA; DeNicola GM; Winter SP; Tuveson DA
Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
[TBL] [Abstract][Full Text] [Related]
20. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
